| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
98,530,000 |
| Market
Cap: |
18.88(M) |
| Last
Volume: |
78,874 |
Avg
Vol: |
78,656 |
| 52
Week Range: |
$0.1916 - $0.1916 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL™ clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM™ capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
31,758 |
51,758 |
77,758 |
93,627 |
| Total Buy Value |
$102,237 |
$190,037 |
$294,295 |
$352,590 |
| Total People Bought |
4 |
4 |
4 |
4 |
| Total Buy Transactions |
4 |
5 |
8 |
11 |
| Total Shares Sold |
0 |
7,084 |
41,479 |
98,636 |
| Total Sell Value |
$0 |
$36,199 |
$179,159 |
$193,613 |
| Total People Sold |
0 |
1 |
5 |
5 |
| Total Sell Transactions |
0 |
1 |
8 |
13 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Meakem John J |
Director |
– • – |
2004-08-04 |
4 |
B |
$4.35 |
$14,355 |
D/D |
3,300 |
45,000 |
2.39 |
- |
|
| Meakem John J |
Director |
– • – |
2004-08-02 |
4 |
B |
$4.43 |
$21,986 |
D/D |
4,900 |
41,700 |
2.39 |
- |
|
| Meakem John J |
Director |
– • – |
2004-07-29 |
4 |
B |
$4.23 |
$28,836 |
D/D |
6,800 |
36,800 |
2.39 |
- |
|
| Mcdade Herbert H |
Director |
– • – |
2004-04-02 |
4 |
S |
$6.25 |
$156,280 |
D/D |
(25,000) |
81,007 |
|
- |
|
| Oracle Associates Llc |
10% Owner |
– – • |
2001-07-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
900,400 |
|
- |
|
205 Records found
|
|
Page 9 of 9 |
|
|
